{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-323753","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2026-07-29T20:15:15+00:00","discovered_at":"2026-07-29T20:16:07.321504+00:00","generated_at":"2026-07-29T20:17:48.461189+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adaptive Biotechnologies Q2 revenue $71.6M (+22% YoY); MRD up 33%; raises FY MRD guidance; CSO transitions to consultant","bullets":["Q2 revenue $71.6M (+22% YoY); MRD revenue $66.2M (+33% YoY); clonoSEQ volume 36,111 (+43% YoY).","Net loss $39.9M (incl. $23.7M loss on OrbiMed settlement); adjusted EBITDA loss improved to $0.7M from $7.2M.","Completed $345M zero-coupon convertible notes offering; repaid OrbiMed Purchase Agreement; cash $371.7M.","Raised FY 2026 MRD revenue guidance to $268M-$278M (from $260M-$270M); total opex guidance narrowed to $350M-$355M.","CSO and co-founder Harlan Robins transitions to strategic consultant role; no disagreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-323753","json":"https://secwatch.observer/filing/0001193125-26-323753.json","markdown":"https://secwatch.observer/filing/0001193125-26-323753.md","text":"https://secwatch.observer/filing/0001193125-26-323753.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000119312526323753/0001193125-26-323753-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000119312526323753/adpt-20260724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T20:17:48.461189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}